| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in CRDF over the last quarter tilts toward buying: insiders added a net 1,443,298 shares worth roughly $1.0M. In the past 30 days, 2 insiders bought and 0 sold. The tilt toward buying has held up recently.
The largest recent buyer is PACE GARY W (Director), now holding an estimated $3.0M in CRDF.
Classified under Biotechnology (Health Care sector), CRDF's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.04M | $2.15M | +1.37M | |
| Dir | 263.4K | $276.6K | - | |
| Dir | 228.1K | $239.5K | - | |
| Dir | 209.3K | $219.8K | - | |
| Dir | 199.2K | $209.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2022 | Levine James E. | Chief Financial Officer | Buy | 30,000 | $1.56 | $46,710.00 | +100.0% | -11.4% | +9.5% | |
| Sep 16, 2022 | Armitage James O | Director | Buy | 13,000 | $1.56 | $20,233.20 | New | -11.4% | +9.5% | |
| Sep 15, 2022 | Tannenbaum Renee P55 | Director | Buy | 10,000 | $1.72 | $17,168.00 | +156.3% | -15.6% | +3.6% | |
| Sep 15, 2022 | Pace Gary W66 | Director | Buy | 150,000 | $1.71 | $256,500.00 | +30.3% | -15.6% | +3.6% | |
| Sep 21, 2021 | Pace Gary W66 | Director | Buy | 30,000 | $6.75 | $202,500.00 | +6.5% | -8.8% | -74.3% | |
| Sep 10, 2021 | Levine James E. | Chief Financial Officer | Buy | 30,000 | $6.47 | $194,000.00 | +50.0% | -8.3% | -54.0% | |
| Mar 26, 2021 | Markin Rodney S | Director | Buy | 2,900 | $10.32 | $29,933.22 | +13.8% | -24.9% | -74.6% | |
| Mar 23, 2021 | Pace Gary W66 | Director | Buy | 10,000 | $10.23 | $102,300.00 | +0.7% | -22.3% | -75.7% | |
| Mar 23, 2021 | Kelemen Vicki | Exec. VP And COO | Buy | 960 | $10.31 | $9,897.60 | +18.8% | -22.3% | -75.7% | |
| Mar 23, 2021 | Erlander Mark | Chief Executive Officer | Buy | 965 | $10.34 | $9,979.74 | +7.1% | -22.3% | -75.7% |